Nanoparticles have emerged as promising drug delivery systems for the treatment of several
diseases. Novel cancer therapies have exploited these particles as alternative adjuvant …

Structural polymeric nanohybrids is presently a popular topic and can be conceived for
numerous functional applications, including the pH-sensitive oral colon-targeted drug …

Poly (lactic-co-glycolic acid)(PLGA) is a US Food and Drug Administration (FDA)-approved
polymer used in humans in the forms of resorbable sutures, drug carriers, and bone …

In a healthcare setting, biofilms are a major source of infection and difficult to eradicate once
formed. Nanoparticles (NPs) can be designed to effectively penetrate biofilms to more …

Background Advances in nutriology have suggested the colon as a superior site for nutrition
absorption. Nutraceuticals, including phytochemicals, probiotics, etc., have received great …

Background Curcumin faces challenges in clinical applications due to its low bioavailability
and poor water solubility. Liposomes have emerged as a promising delivery system for …

Abnormal regulation of cell signaling pathways on cell survival, proliferation and migration
contributes to the development of malignant tumors. Among them, epidermal growth factor …

Abstract Treatment of colon diseases presents one of the most significant obstacles to drug
delivery due to the inability to deliver sufficient drug concentration selectively to the colon …

Poly (lactic-co-glycolic acid)(PLGA) nanoparticles have been extensively studied as carriers
of a wide variety of drugs. However, the variability in protocols and reporting in nanoscience …

Active targeting is a valuable and promising approach with which to enhance the therapeutic
efficacy of nanodelivery systems, and the development of tumor-targeted nanoparticles has …